enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. ‘A huge shock to the system’: Doctors warn about asthma ...

    www.aol.com/huge-shock-system-doctors-warn...

    GSK did price the authorized generic lower than branded Flovent; one package of Flovent HFA in the 110 microgram dose, for example, costs $273.83, about 50% more than the $177.99 wholesale ...

  3. Popular asthma inhaler will be discontinued Jan. 1. Here’s ...

    www.aol.com/news/popular-asthma-inhaler...

    The discontinuation aligns with a change to Medicaid rebates that may have had the inhaler’s manufacturer selling the drug at a loss. Popular asthma inhaler will be discontinued Jan. 1. Here’s ...

  4. Fluticasone/salmeterol - Wikipedia

    en.wikipedia.org/wiki/Fluticasone/salmeterol

    Other side effects from this drug combination may include increased blood pressure, change in heart rate, an irregular heartbeat, increased risk of osteoporosis, cataracts, and glaucoma. [2] Studies have demonstrated the safety of inhaled fluticasone propionate in children.

  5. List of withdrawn drugs - Wikipedia

    en.wikipedia.org/wiki/List_of_withdrawn_drugs

    [1] Alatrofloxacin: 2006 Worldwide Serious hepatotoxicity leading to liver transplant or death. [2] Alclofenac: 1979 UK Vasculitis [3] Alpidem (Ananxyl) 1995 Worldwide Not approved in the US, withdrawn in France in 1994 [4] and the rest of the market in 1995 because of rare but serious hepatotoxicity. [3] [5] Alosetron (Lotronex) 2000 US

  6. Fluticasone - Wikipedia

    en.wikipedia.org/wiki/Fluticasone

    [3] [2] [4] [6] It is on the World Health Organization's List of Essential Medicines . [ 7 ] In 2022, it was the 25th most commonly prescribed medication in the United States, with more than 22 million prescriptions, [ 8 ] [ 9 ] although it is also sold over-the-counter (OTC).

  7. Why pharma giant GSK just made a $300 million bet on ... - AOL

    www.aol.com/news/why-gsk-just-made-300-132129157...

    Lighter Side. Medicare. new

  8. Fluticasone furoate/vilanterol - Wikipedia

    en.wikipedia.org/wiki/Fluticasone_furoate/vilanterol

    In 2013, the drug was approved for use in the United States by the Food and Drug Administration (FDA) for long-term maintenance treatment of airflow obstruction in people with COPD, including chronic bronchitis and emphysema, [6] and the European Medicines Agency approved it as a second-line therapy for the treatment of COPD and asthma. [7]

  9. GlaxoSmithKline Dives on Weak Growth - AOL

    www.aol.com/2012/04/25/glaxosmithkline-dives-on...

    LONDON -- "Big pharma" giant GlaxoSmithKline (NYS: GSK) slightly disappointed its owners today, as its latest results revealed low growth in turnover and earnings. GSK's slow growthAs soon as GSK ...